172 related articles for article (PubMed ID: 36732784)
1. Common mouse models of tauopathy reflect early but not late human disease.
Wenger K; Viode A; Schlaffner CN; van Zalm P; Cheng L; Dellovade T; Langlois X; Bannon A; Chang R; Connors TR; Oakley D; Renard B; Rappsilber J; Hyman B; Steen H; Steen JA
Mol Neurodegener; 2023 Feb; 18(1):10. PubMed ID: 36732784
[TBL] [Abstract][Full Text] [Related]
2. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
3. Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy.
Eun JD; Jimenez H; Adrien L; Wolin A; Marambaud P; Davies P; Koppel JL
Mol Med; 2022 Jul; 28(1):83. PubMed ID: 35858831
[TBL] [Abstract][Full Text] [Related]
4. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
5. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
6. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
7. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology.
Song L; Lu SX; Ouyang X; Melchor J; Lee J; Terracina G; Wang X; Hyde L; Hess JF; Parker EM; Zhang L
Mol Neurodegener; 2015 Mar; 10():14. PubMed ID: 25881209
[TBL] [Abstract][Full Text] [Related]
8. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
9. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
10. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
[TBL] [Abstract][Full Text] [Related]
11. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
12. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
Bhaskar K; Hobbs GA; Yen SH; Lee G
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
[TBL] [Abstract][Full Text] [Related]
14. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse.
Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP
Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964
[TBL] [Abstract][Full Text] [Related]
16. Arterial spin labeling demonstrates preserved regional cerebral blood flow in the P301L mouse model of tauopathy.
Kindler D; Maschio C; Ni R; Zerbi V; Razansky D; Klohs J
J Cereb Blood Flow Metab; 2022 Apr; 42(4):686-693. PubMed ID: 34822744
[TBL] [Abstract][Full Text] [Related]
17. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
Siman R; Cocca R; Dong Y
PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
[TBL] [Abstract][Full Text] [Related]
18. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
19. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
20. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
